Gastrointestinal side effects represent another important factor
Blood Sugar Control: GLP-1 also helps regulate blood sugar by influencing the release of insulin and glucagon
The FDA has received adverse event reports of gastrointestinal disorders associated with semaglutide medications, reflecting widespread problems that many patients and physicians claim were not adequately communicated through warning labels when treatment began
Osei SP, Akomaning E, Florut TF, Sodhi M, Lacy BE, Aldhaleei WA, et al
In summary, GLP-1 medications represent a transformative moment in obesity treatment, with proven efficacy across multiple chronic conditions
Looking To Lose Weight Naturally